摘要
目的:研究祛风除湿、活血养阴中药治疗类风湿关节炎活动期的安全性影响。方法:90例活动期类风湿关节炎病例按性别、年龄、病程均衡后分为基础治疗组、激素组及中药组各30例,分别采用非类固醇抗炎药+改变病情药、小剂量泼尼松+非类固醇抗炎药+改变病情药、中药+非类固醇抗炎药+改变病情药疗8周,评价各组安全性。结果:不良反应的累计积分3组中药组(4.33±2.41)<基础治疗组(8.97±5.12)<激素组(12.67±7.19),3组组间比较差异有统计学意义(P<0.05),结论:中西医结合治疗类风湿关节炎活动期具有更好的安全性。
To study the safety of expel wind-evil and remove wetness, promoting blood flow, invigorating yin Chinese herb in treating active rheumatoid arthritis （RA） . Methods 90 patients with active rheumatoid arthritis were randomly allocated to 3 groups： Single NSAID, DMARD×8 weeks （Basic treatment group） , prednisone in combination with NSAID, DMARD×8 weeks （GC group） or Chinese herb in combination with NSAID, DMARDsx8 weeks （Chinese herb group） . Adverse effects of every group were analyzed respectively. Result Adverse effects score was significantly different among the 3 groups. Conclusions Treatment of active rheumatoid arthritis with integrated traditional and westen medicine was the safest among the 3 groups.
出处
《中国民族民间医药》
2009年第9期40-41,共2页
Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词
关节炎
类风湿
中药
安全性
Arthritis, rheumatoid
Chinese herb
safety
